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Progressive loss of renal function is associated with a
dysregulation of circulating T cells that may underlie their
impaired T-cell immunity. Here we tested whether end-stage
renal disease (ESRD)-related T-cell alterations are compatible
with the concept of premature immunological aging.
Younger patients (25–45 years old) with ESRD were found to
resemble older healthy controls (60–80 years old) as they had
a significant loss of naive T cells and a relative increase of
memory T cells showing progressive terminal differentiation.
A significant decrease in the content of T-cell receptor
excision circles and telomere length in patients with ESRD
confirmed these phenotypic data. The loss of naive T cells in
patients with ESRD was associated with an excessive age-
related decrease of recent thymic emigrants, indicating a
premature decline in thymic function. Additionally, increased
homeostatic proliferation of naive T cells was found in
patients with ESRD, similar to that of older healthy
individuals, with an increased susceptibility for activation-
induced apoptosis. Therefore, both decreased thymic output
and increased susceptibility of naive T cells for apoptosis may
play a role in the loss of naive T cells in ESRD patients. Thus,
our results are compatible with premature aging of the T-cell
system of patients with ESRD comparable with that of
healthy individuals 20–30 years older.
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Progressive loss of renal function is associated with clinical
signs of decreased T-cell immunity, such as a poor generation
of antigen-specific T cells after vaccination and an increased
susceptibility for infections.1,2
Circulating T cells can be characterized as naive (antigen-
inexperienced) or memory (antigen-experienced) cells.
Differential coexpression of chemokine receptor CCR7
(chemokine (C-C motif) receptor 7) and CD45RO can be
used to identify memory T-cell sub-populations that
represent an increasing state of differentiation: central-
memory (able to home into lymphoid tissues), effector-
memory (exerting direct effector functions), and EMRA
(highly differentiated effector CD8 T cells lacking CD45RO
expression) T cells.3,4 This increase in differentiation is
associated with a progressive increase in expression of the
terminal differentiation marker CD57 and loss of the
costimulatory molecule CD28 (CD28null) on the surface of
T cells.4
In aging healthy individuals, the number of circulating
T cells only slightly decreases with age, although the thymic
output of new T cells (recent thymic emigrants (RTEs)) in
the circulation is greatly reduced after the age of 40 years.5
However, T-cell numbers are largely conserved by homeo-
static proliferation of both naive and memory T cells,
eventually leading to a contracted naive T-cell population but
a relatively preserved memory T-cell population.
In the very old individuals, a marked increase in naive
T-cell proliferation may be observed, a declining CD4/CD8
T-cell ratio, and a relative increase of CD28null T cells.5–7 The
latter findings are associated with increased mortality and
decreased responsiveness to vaccination, and therefore
considered an immunological risk profile.8,9 These observa-
tions on physiological aging of the T-cell immune system
seem similar to what has been consistently documented in
end-stage renal disease (ESRD) patients: lymphopenia,
relative expansion of CD28null T cells, and decreased CD4/
CD8 ratio.3,10–12
During T-cell receptor rearrangement within the thymus,
T-cell receptor excision circles (TRECs) are formed that
remain as circular genomic DNA remnants within the
nucleus and are diluted with every T-cell division. A decrease
in TREC content in combination with loss of telomere length
of T cells therefore reflects the thymic output and replicative
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history of circulating T cells and can be used to establish the
immunological age of T cells.13,14
In this study we have tested the hypothesis that the ESRD-
related changes of the T-cell compartment are in fact
compatible with the concept of premature immunological
aging.
RESULTS
T-cell differentiation in relation to age and ESRD
The clinical and demographical characteristics of ESRD
patients and healthy controls (HCs) are shown in Table 1.
The variables age, ESRD, dialysis, and the interaction term of
age and ESRD were analyzed in a univariate general linear
model for their association with T-cell numbers and
differentiation patterns (P-values are shown in Table 2). In
addition, data on T-cell differentiation of ESRD patients and
HCs are shown in Figures 1 and 2.
In accordance with previous studies,10,12,15 we could not
find statistically significant differences in T-cell parameters
between patients with or without dialysis. Absolute numbers
of CD4 and CD8 T cells showed a significant age-related
decline in ESRD patients and HCs (Figure 1a and b). A
statistical significant interaction between age and ESRD was
only observed for absolute CD4 T-cell numbers (Table 2).
The naive CD4 and CD8 T-cell subsets declined with age
in both ESRD patients and HCs, with a statistically
significant interaction between age and ESRD for only naive
CD8 T cells (Table 2). The effect of ESRD on naive T cells was
already present in the young age group (Figure 1c and d).
The memory CD4 T-cell population decreased signifi-
cantly in ESRD patients (Figure 1e) with a statistically
significant interaction between ESRD and age (Table 2). The
young ESRD patients already showed a relative expansion of
effector memory CD4 T cells (Tem), which was significantly
more pronounced in the old ESRD patients (young versus
old ESRD; 36.9 versus 42.4% of CD4 T cells, Po0.0001,
Figure 2a). This was reflected by the highly significant
P-values for the relation between CD4 Tem and ESRD and for
the relation between CD4 Tem and age (Table 2).
The absolute number of CD8 memory T cells remained
relatively unchanged (Figure 1f), although a significant
relation was found with ESRD and the interaction term with
age (Table 2). Therefore, the relative decrease of naive T cells
was most evident in the CD8 T cells (Figure 2b). Such a
difference was expected as it is known that the capacity to
expand memory T cells is better for CD8 T cells when
compared with CD4 T cells.16
The differentiation of memory CD8 T cells increased with
age (Figure 2b), showing a significant increase in the
percentage of Tem (19.9–22.5%, Po0.004) and Temra cells
(16.2–21.0%, Po0.001) in HCs. In ESRD patients, these
changes were observed at an earlier age and reached
significantly higher percentages at old age (CD8 Tem 23.7%
and Temra 29.1%, Po0.001 compared with young ESRD
patients and old HCs). The univariate general linear model
confirmed the highly significant association of age
(Po0.001) and to a lesser extent ESRD (P¼ 0.04) with the
percentage of Temra cells (Table 2).
Overall, these data on circulating T cells indicate that age-
related changes observed in old HCs are already present in
ESRD patients 30 years younger.
Expression of terminal differentiation marker CD57 and
CD28null T cells
The percentage of CD28null or CD57þ memory T cells was
determined as these markers are associated with progressive
differentiation of memory T cells. The percentages of
CD28null memory T cells were increased in old HCs and
young ESRD patients compared with young HCs, although
Table 1 | Clinical and demographic characteristics of patients
with end-stage renal disease and healthy controls
End-stage renal
disease patients
Healthy
controls
Number of individuals 137 144
Age in years 52.5±3.9a 53.3±4.0
Male 67.9.0% 63.9%
Patients on hemodialysis 97 —
Duration of dialysis in years (median with
interquartile range)
2.4 (1.5–3.2) —
Underlying kidney disease
Hypertensive nephropathy 43.8% —
Primary glomerulopathy 14.6% —
Diabetic nephropathy 8.0% —
Polycystic kidney disease 8.0% —
Reflux nephropathy 7.3%
Other 10.9% —
Unknown 7.3% —
aData are given in means with s.d.
Table 2 | The P-values for the association of ESRD, dialysis,
and age with parameters of circulating T cells, analyzed by a
univariate general linear model
Hemodialysisa Ageb ESRD Age ESRDc
CD4 T cells (106/ml) 0.81d 0.01 o0.001 0.02
CD4 naive T cells (106/ml) 0.58 o0.01 o0.001 0.22
CD4 memory T cells (106/ml) 0.66 0.28 o0.001 o0.01
% Naive T cells 0.27 0.01 0.16 0.82
% Central-memory T cells 0.13 0.82 0.04 0.22
% Effector-memory T cells 0.42 0.03 o0.001 0.18
% CD28null memory T cells 0.57 o0.001o0.01 0.95
% CD57þ memory T cells NA 0.92 o0.01 o0.01
CD8 T cells (106/ml) 0.66 o0.01 o0.001 0.56
CD8 naive T cells (106/ml) 0.48 o0.001o0.001 0.02
CD8 memory T cells (106/ml) 0.70 0.32 0.03 0.02
% Naive T cells 0.58 o0.001 0.34 o0.001
% Central-memory T cells 0.40 o0.001o0.001 o0.001
% Effector-memory T cells 0.12 o0.01 0.13 0.01
% EMRA T cells 0.50 o0.001 0.04 0.36
% CD28null memory T cells 0.69 o0.01 0.02 0.96
% CD57þ memory T cells NA 0.98 0.26 0.33
Abbreviations: ESRD, end-stage renal disease; NA, not available.
aESRD with or without hemodialysis.
bAge categories of young (25–45 years) and old (65–80 years) were used.
cInteraction term for age and ESRD in the statistical model.
dThe P-values are shown.
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statistical significance was not reached (Figure 2c and d).
However, the old ESRD patients showed a significantly higher
percentage of CD28null CD4 (4.3–10.7%, Po0.001) and CD8
T cells (33.3–49.1%, Po0.001). Analysis by a univariate
general linear model (Table 2) revealed a highly significant
and independent association between age (Po0.001 for
CD28null CD4 T cells and Po0.01 for CD28null CD8
T cells) and ESRD (Po0.01 for CD28null CD4 T cells and
P¼ 0.02 for CD28null CD8 T cells).
Only in the memory CD4 T-cell population of ESRD
patients, the percentage of CD57þ cells was significantly
increased (Figure 2c), with a statistically significant interac-
tion between age and ESRD (Table 2).
The CD28 and CD57 expression patterns on circulating
T cells in ESRD patients confirmed the trend of premature
aging but appeared less discriminative in comparison with
differentiation patterns using CD45RO and CCR7.
T cells of ESRD patients show increased loss of TRECs and
attrition of telomeres
Dilution of TREC content in the T-cell population (resulting
in a higher threshold cycle in the TREC assay) is a result of
age-related decrease of thymic T-cell output and T-cell
replication history in healthy individuals. We confirmed this
relation (Figure 3) and, in addition, a highly significant
independent association of both ESRD (P¼ 0.002) and age
(Po0.001) with TREC content could be shown by multi-
variate linear regression analysis. The relative telomere
length (RTL) of both CD4 and CD8 T cells decreases with
normal aging as a consequence of repetitive T-cell division
(Figure 4a and b). Again, the ESRD patients, either young or
old, showed a significantly lower CD4 T-cell RTL compared
with HCs (Figure 4c). Multivariate linear regression analysis
showed a statistically significant independent association of
CD4 T-cell RTL with age (Po0.001) and ESRD (P¼ 0.007).
The linear regression lines for CD8 T cells in aging healthy
individuals and ESRD patients were almost identical to the
lines observed in CD4 T cells, but a higher variability of RTL
in CD8 T cells was noted. Multivariate linear regression
analysis showed a statistically significant independent asso-
ciation of CD8 T-cell RTL with age (P¼ 0.02) but not ESRD
(P¼ 0.10).
Based on RTL and TREC content of T cells, the
immunological age of ESRD patients was increased by
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Figure 1 |Absolute number of circulating CD4 and CD8 T cells in young (25–45 years, n¼ 60) and old (60–80 years, n¼ 60) end-stage
renal disease (ESRD) patients compared with age-matched healthy controls (HCs; young HCs, n¼ 60 and old HCs, n¼ 60). The total
number of (a) CD4 and (b) CD8 T cells, (c) CD4 T naive, (d) CD8 T naive, as well as (e) total memory (Tmem) CD4 and (f) CD8 T cells
are shown. Results are given in means with s.e.m. The black bars represent the young individuals whereas the white bars correspond to
the old individuals.
210 Kidney International (2011) 80, 208–217
or ig ina l a r t i c l e MGH Betjes et al.: Premature T-cell aging
20–30 years compared with the chronological age-matched
HCs.
Increased homeostatic proliferation of naive T cells and loss
of RTEs
The culprit finding in old age, especially in ESRD patients, is
the relative and absolute decrease in circulating naive T cells,
particularly in the CD8 T-cell population. The presence of
CD31 on naive T cells can be used to identify RTEs (reviewed
in Kohler and Thiel17). Using this marker we observed a
significant age-related decrease in the number of circulating
CD31þ naive CD4 and CD8 T cells, which was most evident
in old ESRD patients (on average,470% decrease compared
with young ESRD patients and old HCs, Figure 5a and b).
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Figure 2 |Composition of peripheral CD4 and CD8 T-cell subsets. The relative distribution of T-cell subsets within the (a) CD4 and
(b) CD8 T-cell populations of young (25–45 years, n¼ 60) and old (60–80 years, n¼ 60) end-stage renal disease (ESRD) patients compared
with age-matched healthy controls (HCs; young HCs, n¼ 60 and old HCs, n¼ 60) are shown. T-cell subsets are naive T cells, central-memory
T cells (CM), effector-memory (EM) T cells, and EMRA CD8 T cells. The black bars represent the young individuals and the white bars
correspond to the old individuals. The P-values above the brackets represent the statistical significance for the difference between T-cell
subsets of old and young healthy controls or the difference between old and young ESRD patients. The asterisks represent the statistical
significance for the difference between T-cell subsets of young HCs compared with young ESRD patients, and T-cell subsets of old HCs
compared with old ESRD patients (*Po0.01, **Po0.001, ***Po0.0001). The lower panel shows the percentage of CD28– (CD28null) and
CD57þ on (c) memory CD4 and (d) CD8 T cells of young (25–45 years, n¼ 20) and old (60–80 years, n¼ 20) ESRD patients compared with
age-matched HCs (young HCs, n¼ 20 and old HCs, n¼ 20). All bars represent means with s.e.m.
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Figure 3 |Quantification of T-cell receptor excision circles (TRECs) within the peripheral blood mononuclear cell population as
determined by real-time quantitative PCR (qPCR). The threshold cycle (Ct) is the number of amplification cycles needed to detect the
TRECs and is a relative measure, inversely related with the concentration of TRECs. Control for DNA input was done by performing a qPCR
for albumin. The difference between Ct for TRECs and Ct for albumin (DCt) is calculated and depicted. (a) The relation of DCt with age in
end-stage renal disease (ESRD) patients on hemodialysis (n¼ 40, closed symbols) and healthy controls (N¼ 59, open symbols) is shown by
depicting the linear regression lines (Po0.01 for the difference between both lines). (b) Patients and healthy controls were separated in a
young group (age 25–45 years, black bars) and an old group (age 60–80 years, white bars) and statistically significant differences between
the groups are shown.
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The univariate general linear model showed a highly
statistical significant association of age, ESRD, and the
interaction between age and ESRD (all P-values o0.001)
with both CD31þ naive CD4 and CD8 T cells (Table 3).
The percentage of dividing T cells can be established by
staining for the expression of Ki67, an antigen only present in
the G1M phase of cell division. Old HCs and ESRD patients
had a significant increased percentage of Ki67þ naive CD4 T
cells (0.88 and 1.02% respectively, Po0.05 compared with
0.54% in young HCs, Figure 5c). A significant correlation was
found between the frequency of Ki67þ naive T cells and the
absolute number of naive T cells (R¼0.33, Po0.05),
indicating that decreasing numbers of naive T cells were not
caused by decreased proliferation, but actually were asso-
ciated with an increased frequency of dividing naive T cells.
ESRD and the interaction term of ESRD and age were both
significantly associated with the percentage of Ki67þ naive
CD4 T cells (Table 3).
No age- or ESRD-related changes were observed in Ki67þ
memory T cells (Figure 5d and Table 3).
Increased naive T-cell apoptosis and expression of CD95 in
ESRD patients
Besides decreased thymic output of naive T cells, increased
T-cell apoptosis, as shown by others,18 may underlie the loss
of naive T cells in ESRD patients. We observed a similar
spontaneous apoptosis in vitro of T cells from ESRD patients
compared with HCs (Figure 6a and c). However, a
significantly increased activation-induced apoptosis of CD8
and CD4 T cells of ESRD patients compared with HCs (for
CD4 T cells, 27.8 versus 22.2%, P¼ 0.04; for CD8 T cells, 32.8
versus 27.6%, P¼ 0.03) was found (Figure 6b and d). This
difference could be in particular attributed to a significantly
higher apoptosis rate in naive CD4 and CD8 T cells and
effector-memory CD4 T cells (Figure 6b and d and Table 4).
We could not identify an association between susceptibility of
T cells for activation-induced apoptosis and age in both
patients and HCs (Table 4). The percentage of CD95-
expressing naive CD4 T cells significantly increased with age
in HCs (Figure 7a). A statistically significant association of
age and the interaction term of age and ESRD, with CD95
expression on naive T cells, was found in the general linear
model (Table 3). The percentage of naive CD4 cells
expressing the antiapoptotic CD279 molecule (programmed
death receptor 1) was unaffected by age and ESRD (Figure
7e–h). The expression of CD95 on naive CD8 T cells was
significantly associated with age but not ESRD (Figure 7c and
Table 3).
The expression of CD95 and CD279 on memory CD4 and
CD8 T cells was high (on average 90%, Figure 7) and
unaffected by age and/or ESRD (Table 3).
Collectively, these data show that increased CD95 expres-
sion and activation-induced apoptosis of naive T cells in
ESRD patients may contribute to loss of naive T cells,
irrespective of age.
DISCUSSION
The results of this study show that based on several
immunological parameters, such as T-cell numbers and
differentiation, TREC content, and RTL of T cells, ESRD is
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Figure 4 |Relative telomere length (RTL) of CD4 and CD8 T cells. RTL was assessed by comparing the average telomere length in (a) CD4
and (b) CD8 T-cell populations of end-stage renal disease (ESRD) patients on hemodialysis (closed symbols) and healthy controls (open
symbols) to a standardized control. The relation of RTL with age in ESRD patients (n¼ 30) and healthy controls (N¼ 28) is shown by
depicting the linear regression lines (Po0.01 for the difference between both lines for CD4 T cells). The RTL of (c) CD4 and (d) CD8 T cells
from patients and healthy controls were separated in a young group (age 25–45 years, black bars) and an old group (age 60–80 years, white
bars) and statistical significant differences between the groups are shown.
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associated with excessive premature aging of the T-cell system
over an age range from 20 to 80 years.
In accordance with previous studies, we noted that a
substantial decline of naive CD4 and CD8 T cells is the key
finding of an aged T-cell system. The subsequent homeostatic
proliferation of memory T cells is accompanied by increased
numbers of T cells that reach the effector-memory and
EMRA T-cell stage of development. Numerous studies have
shown that these terminally differentiated T-cell phenotypes
are associated with increased effector functions (for example,
cytokine secretion and cytotoxicity),10,19 loss of telomere
length,20 and decreased proliferative capacity.21 Although
data are few, this association has also been documented in
ESRD patients.10,22 Based on the results of the phenotypical
T-cell analysis, it may be concluded that ESRD is associated
with excessive premature immunological aging. Next, we
performed TREC content analysis and determined relative
T-cell telomere length to support this conclusion, as
expression of T-cell surface molecules may be influenced by
other ESRD-related factors. Both TREC content and RTL
showed a decline with age, but again this was significantly
greater in ESRD patients when compared with the HCs. In
particular, the RTL of ESRD T cells was substantially shorter
in all decades, whereas the TREC content at a young age
seemed affected to a lesser extent by ESRD.
As expected, the number of circulating CD31þ naive T
cells, reflecting RTEs, decreased substantially with age in
healthy individuals. However, young ESRD patients already
had similar low number of RTEs as the old HCs, indicating
premature diminished thymic function. The findings are
reminiscent of young adults thymectomized during early
childhood who show substantial loss of their naive T-cell
compartment with accumulation of T cells expressing the
aging marker CD57.16,23
Involution of the thymus in combination with lifelong
antigenic stimulation of the naive T cells is generally
considered the most likely cause of a decreased naive T-cell
population in old HCs.24 Data of thymic function are lacking
for ESRD patient,25 but in animal experiments acute renal
failure leads to involution of thymus and spleen.26,27
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Figure 5 |Absolute numbers of CD31+ CD4 and CD8 T-cell subsets and percentages of Ki67+ within the CD4 T-cell compartment.
The upper panel shows the absolute number of CD31+ naive (a) CD4 and (b) CD8 T cells of young (25–45 years, n¼ 20; black bars) and old
(60–80 years, n¼ 20; white bars) end-stage renal disease (ESRD) patients on hemodialysis compared with age-matched healthy controls
(HCs; young HCs, n¼ 20 and old HCs, n¼ 20). The lower panel shows the percentage of Ki67+ cells among (c) naive and (d) memory CD4 T
cells of ESRD young (n¼ 20) and ESRD old (n¼ 20) compared with age-matched HCs young (n¼ 20) and HCs old (n¼ 20). The results are
given in means with s.e.m. Only statistically significant differences (Po0.05) between groups are shown.
Table 3 | The association of end-stage renal disease (ESRD)
and age with output of recent thymic emigrants (CD31+ naive
T cells), percentage of proliferating cells (Ki67+ T cells), and
the percentage of cells expressing proapoptotic (CD95) and
antiapoptotic (CD279) cell surface molecules
Agea ESRDb Age ESRDc
CD31+ naive CD4 T cells (106/ml) o0.001d o0.001 o0.001
CD31+ naive CD8 T cells (106/ml) o0.001 o0.001 o0.001
% Ki67+ naive CD4 T cells 0.08 0.01 0.01
% Ki67+ memory CD4 T cells 0.92 0.83 0.80
% CD95+ naive CD4 T cells 0.02 0.07 0.03
% CD95+ memory CD4 T cells 0.63 0.83 0.56
% CD95+ naive CD8 T cells o0.001 0.78 0.18
% CD95+ memory CD8 T cells 0.56 0.91 0.46
% CD279+ naive CD4 T cells 0.02 0.31 0.05
% CD279+ memory CD4 T cells 0.64 0.71 0.74
% CD279+ naive CD8 T cells 0.22 0.08 0.22
% CD279+ memory CD8 T cells 0.32 0.273 0.62
P-values are shown using a univariate general linear model.
aAge categories of young (25–45 years) and old (65–80 years) were used.
bESRD with or without dialysis.
cInteraction term for age and ESRD in the statistical model.
dP-values are shown.
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Therefore, in young ESRD patients, loss of thymic output
could possibly contribute to the decline in CD31þ naive
T cells. However, in the old ESRD patients the thymic
function is already absent. These patients showed an even
more dramatic premature aging of T cells, indicating that loss
of thymic function alone is not a sufficient explanation.
In accordance with previous studies in healthy individuals,
we observed that the age-related loss of naive T cells in both
HCs and ESRD patients is associated with an increased naive
T-cell turnover.28,29 These results indicate that loss of naive
T cells leads to an increased frequency of dividing naive
T cells by a homeostatic response.28 However, it is evident
that ESRD patients are not able to build up an adequate
homeostatic response as their naive T-cell numbers remain
substantially decreased. This suggests the possibility of a
relative deficiency of cytokines that control homeostatic
T-cell proliferation, most notably interleukin-7, as we have
documented previously in a group of middle-aged ESRD
patients.3
Next, to a decreased thymic output or a relative lack of
T-cell homeostatic cytokines, our results indicate that, in
particular, naive CD4 and CD8 T-cell populations are
susceptible to activation-induced apoptosis in vitro. Also,
naive T cells of HCs and ESRD patients showed a
significantly age-related increased expression of the proa-
poptotic marker CD95, confirming previous data in healthy
aging individuals.30 Therefore, increased activation-induced
apoptosis of naive T cells may contribute to their excessive
depletion in ESRD patients. However, it should be kept in
mind that homeostatic T-cell proliferation is also associated
with expression of CD95 and apoptosis,31 which constitutes a
natural feed-back mechanism.32,33
In conclusion, normal aging of the T-cell system results in
a contracted naive T-cell population because of lowered
numbers of RTEs, leading to increased homeostatic T-cell
proliferation and a relative conserved, but more differen-
tiated, pool of memory T cells. ESRD patients show an
excessively prematurely aged T-cell system that may be
caused by a combination of decreased thymic output and
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Figure 6 | Spontaneous and activation-induced apoptosis of CD4 and CD8 T cell subsets. The percentage of early apoptotic and late
apoptotic or necrotic (a, b) CD4 and (c, d) CD8 T cells after 18 h culture in medium without stimulation (spontaneous apoptosis) and with
1 mg/ml phytohemagglutinin (activation-induced apoptosis) within the different T-cell subsets. T-cell subsets are naive T cells, central-
memory T cells (CM), effector-memory (EM) T cells, and EMRA CD8 T cells. The data of healthy controls (HCs, n¼ 20) and end-stage renal
disease patients on hemodialysis (ESRD, n¼ 20) are shown. The bars represent the average cumulative percentage of early apoptotic
(white bars) and late apoptotic/necrotic (black bars) cells within every T-cell subset. Only statistically significant differences (Po0.05)
between groups are shown.
Table 4 | The association of end-stage renal disease (ESRD)
and age with the percentage of activation-induced apoptosis
in different subsets of circulating T cells, analyzed by a
univariate general linear model (P-values are shown)
Agea ESRD Age ESRDb
Naive CD4 T cells 0.73c 0.01 0.15
Central-memory CD4 T cells 0.98 0.33 0.26
Effector-memory CD4 T cells 0.60 0.03 0.02
Naive CD8 T cells 0.490 0.05 0.126
Central-memory CD8 T cells 0.21 0.27 0.16
Effector-memory CD8 T cells 0.10 0.28 0.15
EMRA CD8 T cells 0.026 0.21 0.14
aAge categories of young (25–45 years) and old (65–80 years) were used.
bInteraction term for age and ESRD in the statistical model.
cThe P-values are shown.
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increased activation-induced apoptosis, with a relative
insufficient increase in homeostatic proliferation.
The consequences of an aged immune system, either
prematurely aged or not, are probably multiple. A contracted
naive T-cell compartment will not be able to mount a similar
immune response to foreign antigens and shows a decreased
proliferation capacity in vitro.5 In vivo, vaccination responses
decrease with age and are associated with low CD4 T-cell
levels and an increased percentage of CD28null memory
T cells.8 The increased numbers of proinflammatory
CD4CD28null T cells pose a risk for atherosclerotic plaque
instability and lower epoietin responsiveness in ESRD
patients.34–36 Importantly, therapeutic strategies are now
developed to rejuvenate the human T-cell system. Of specific
interest is recombinant interleukin-7, as it has shown a
remarkable capability to expand the naive T-cell population
and decrease the number of terminally differentiated
T cells.37,38
Finally, it is important to realize that the degree of
premature aging varies considerably, not only in ESRD
patients but also in healthy individuals.10,16,29 The reason for
this large variation is not known but indicates that some
individuals seem to be better protected than others against
aging of their immune system. The clinical consequences for
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such ESRD patients may translate in a decreased suscept-
ibility to infections but an increased risk for acute rejection
after kidney transplantation.22
MATERIALS AND METHODS
Patients with ESRD, defined as a glomerular filtration rate of
p15ml/min with or without hemodialysis, were included. Patients
with infection, malignancy, autoimmune disease, or with a history
of immunosuppressive drugs (including previous kidney transplan-
tations) were excluded. Young ESRD patients without renal
replacement therapy (n¼ 20) and with hemodialysis (n¼ 40) were
recruited from stable patients aged 25–45 years (median 32 years).
Old ESRD patients without renal replacement therapy (n¼ 20) and
with hemodialysis (n¼ 40) were recruited from stable patients aged
60–80 years (median 72 years). For phenotypical analysis of
circulating T-cell subsets, both patients with and without renal
replacement therapies were included. For all other assays, only
hemodialysis patients were included. Additional hemodialysis
patients and HCs were included for determination of T-cell telomere
length and the TRECs from 20 to 80 years of age. The clinical and
demographic characteristics of all patients included in this study are
shown in Table 1.
Hemodialysis patients were treated according to the European
Best Practice Guidelines (EBPG) with strict control of dialysis water
quality.34 All hemodialysis patients underwent dialysis treatment
thrice weekly for at least 4 h. For every ESRD patient, a HC was
included, matched for age, sex, and cytomegalovirus seropositivity.
All individuals included gave informed consent and the local
medical ethical committee approved the study. It was conducted
according to the Declaration of Helsinki Principles and in
compliance with International Conference on Harmonization/Good
Clinical Practice regulations.
T cells and differentiation profile
Peripheral blood mononuclear cells (PBMCs) were isolated from
heparinized peripheral blood samples.39 Blood samples were taken
before the start of a hemodialysis session.
The differentiation state of the different T lymphocytes was
determined using flow cytometry upon cell surface staining of
PBMCs, as previously described in detail. The T-cell subsets were
defined as follows: naive T cells being CCR7þ and CD45RO;
central memory T cells (CM) as CD45ROþ and CCR7þ ; effector
memory (EM) T cells as CD45ROþ and CCR7, and EMRA CD8 T
cells as CD45RO and CCR7 (ref. 3).
CD28 and CD57 expression on T cells was analyzed by co-
staining of memory (CD45ROþ ) T cells with phycoerythrin or
peridinin chlorophyll-Cy5.5 (PerCP-Cy5.5)-labeled anti-CD28 (both
from BD, Erembodegem, Belgium) and allophycocyanin-labeled
anti-CD57 (Biolegend, Europe BV, Uithoorn, The Netherlands).
Phycoerythrin-labeled anti-CD31 (Biolegend) was used to identify
the population of RTEs among naive T cells.
Ki67 staining of T cells
Ki67 is a nuclear antigen expressed selectively in cells at
the G–M stages of cell division, thereby allowing for quantification
of the percentage of cells in division. Fluorescein isothiocyanate
(FITC)-labeled anti-Ki67 was after fixation and permeabilization
of cells (IntraSure Kit BD). The frequency of Ki67þ cells was
determined in CD45RO-negative and -positive CD4 and CD8
T cells. For CD4 T cells, the frequency of Ki67þ cells was also
determined within CD31þ and CD31– naive T cells (CD45RO–
CD4 T cells).
Apoptosis
Apoptosis sensitivity of the different CD4 and CD8 T-cell sub-
sets was assessed using phycoerythrin-labeled anti-CD95 (FAS-
receptor; Biolegend) and FITC-labeled anti-CD279 (program death
receptor 1; BD).
Using the apoptosis kit (BD Pharmingen, Erembodegem,
Belgium) containing FITC-labeled annexin-V in combination with
the DNA stain, 7-amino-actinomycin-D (7-AAD), viable cells
(negative for both annexin V and 7-AAD), early apoptotic cells (only
positive for annexin V), and late apoptotic or necrotic cells (positive
for both annexin V and 7-AAD) can be distinguished. These
frequencies were determined for unstimulated PBMCs and upon
overnight stimulation of PBMCs with 1mg/ml phytohemagglutinin.
TREC assay
TREC content allows for determination of thymic T-cell output in
combination with T-cell replication history.14 A combination of
two primers and a hydrolysis probe specific for the so-called
dREC(TCRD)-cJa(TCRA) TREC (sjTREC) was employed. TaqMan
quantitative PCR was performed on 50 ng DNA in a 25 ml reaction
mixture containing 700 nmol/l of each primer 50-TCGTGAGA
ACGGTGAATGAAG-30 and 50-CCATGCTGACACCTCTGGTT-30,
150 nmol/l of hydrolysis probe 50-FAM) CACGGTGATGCATAGGC
ACCTGC-30 (TAMRA), and 12.5ml 2 TaqMan Universal
PCR Master Mix (Applied Biosystems, Nieuwerkerk a/d Ijssel,
The Netherlands). Quantification of the DNA amount in each
sample was performed using a quantitative PCR of the single-copy
albumin gene. All reactions were performed in duplicates, unless a
threshold cycle (Ct) difference between replicates of 41.5
necessitated to repeat the PCR experiment. Averages values of each
sample were used for further data analysis.
Telomere length assay
Telomere length of circulating T cells was determined by the flow
fluorescent in situ hybridization technique. Briefly, PBMCs were
stained with either CD4- (Beckman-Coulter, BV, Woerden,
The Netherlands) or CD8-biotin (Biolegend) followed by strepta-
vidin-Cy5 (Biolegend) and fixed and permeabilized. Subsequently,
the relative telomere length was determined using the telomere
PNA-kit/FITC (Zebra Bioscience BV, Enschede, The Netherlands)
according to the manufacturer’s instruction. Using the subcell line
1301 of CCRF-CEM (known for its long telomeres), a relative
telomere length was calculated:
RTL ¼
ðmedian FL1 sample cells with probemedian FL1 sample cells without probeÞ
DNA index of control cells100
ðmedian FL1 sample cells with probemedian FL1 sample cells without probeÞ
DNA index of sample cells
Statistical analysis
Analysis of variance was used for multiple data sets with post hoc
statistical analysis for the difference between two groups using the
Bonferroni test for multiple comparisons. In addition, the univariate
general linear model was employed to test whether ESRD with or
without hemodialysis, ESRD per se, age, and the interaction term of
age and ESRD were significantly associated with all immunological
parameters acquired. Differences between groups were analyzed
using Student’s t-test, when the variable was normally distributed,
and otherwise using Mann–Whitney test. Associations between
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variables were assessed by performing Pearson’s or Spearman’s rank
correlation test, depending on whether the data were normally
distributed or not. The association of age and ESRD with TREC
content and RTL was tested by multivariate linear regression. All
statistical tests were performed two sided and a P-value of o0.05
was considered significant. The SPSS software version 15.0 (SPSS,
IBM, Somers, NY) was used for all statistical tests.
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